Polyclonal Antibodies
Anti-EAF1 Polyclonal Antibody for WB, ELISA - Q96JC9
Item Number : CM0022219
Price varies based on specs and customizations
- Application
- WB, ELISA
- Cross Reactivity
- Human, Rat
- Protein Weight
- 29kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | EAF1 Rabbit pAb |
| Remarks/Alias | EAF1 |
| Species | Human |
| GeneID (Human) | 85403 |
| GeneID | 85403 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 50-120 of human EAF1 (NP_149074.3). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, ELISA |
| Cross Reactivity | Human, Rat |
| SWISS | Q96JC9 |
| Protein Weight | 29kDa |
| Shipping | Ice bag |
Biological Background: EAF1 Function and Localization
- EAF1 (ELL-associated factor 1) is a transcriptional activator that enhances the elongation activities of ELL and ELL2, key regulators of RNA polymerase II transcription elongation.
- It is primarily localized within the nucleus, concentrating in nuclear speckles, which are enriched in pre-mRNA splicing factors, and Cajal bodies, involved in snRNP biogenesis.
- EAF1 exhibits broad tissue expression, with strong detection in heart, brain, placenta, lung, liver, skeletal muscle, kidney, pancreas, spleen, prostate, testis, small intestine, and colon; expression is low in the thymus.
- The protein is classified as a phosphoprotein, suggesting that its activity or localization may be modulated by phosphorylation events.
- Alternative splicing of the EAF1 gene generates multiple transcript variants, potentially producing isoforms with distinct functional properties.
- As a component of the reference proteome, EAF1 is well-conserved and serves as a model for studying transcription regulation and elongation control.
Experimental Guidance and Technical Tips
- The immunogen corresponds to amino acids 50–120 of human EAF1; consider validating specificity using cells with EAF1 knockout or knockdown to confirm band identity in Western blot.
- For Western blot, a primary band is expected at approximately 29 kDa; however, alternative splicing may yield additional isoforms—validate in your specific tissue or cell lysate.
- ELISA performance depends on optimal coating conditions and antibody–antigen pairing; careful optimization of dilutions and blocking steps is advised.
- Reported cross-reactivity includes human and rat; if testing other species, perform a sequence alignment of the immunogen region and conduct pilot experiments.
- Usage beyond WB and ELISA (e.g., IHC, IF) has not been validated; thorough optimization is required before applying to other techniques.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your integrated partner for IVD raw materials, bridging the gap from concept to clinical application. For transcription regulation research, including EAF1-related targets, we supply validated antibody pairs, optimized monoclonal and polyclonal antibodies, and bulk ancillary reagents. Whether you need rare-target sourcing or scalable production, our one-stop platform accelerates your assay development and manufacturing timelines.
Product Datasheet
Anti-EAF1 Polyclonal Antibody for WB, ELISA - Q96JC9
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!